Elliot Israel's guest appearances

Elliot Israel

NEJM Interviews

Lungcast

Cecile Richards

Nicholas Bagley

Scott Burris

Wendy Parmet

David Kessler

Robert Aronowitz

Aaron Kesselheim

Mark Hall

George Church

David Hunter

Vivian Lee

George Annas

John McDonough

Sean Duffy

Robert Schwartz

OwlTail

In recognition of May’s Asthma Awareness Month, this episode highlights our conversation with Dr. Juan Carlos Cardet at University of South Florida and Dr. Elliot Israel at Brigham and Women’s Hospital about the most common respiratory disease in the U.S. It provides a deep dive into the guideline-supported SMART strategy, role of COVID-19 in current asthma risks, and research into the medical and financial impacts of asthma on the U.S. patient population.  Episode highlights 0:16 The Discovery of Asthma 2:12 Introducing Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH 3:20 Defining the SMART asthma strategy 5:46 The slow rollout of SMART 10:19 The strategy and findings of the PREPARE trial 21:41 How to initiate patient-activated reliever-triggered inhaled corticosteroid 25:15 The effect of COVID-19 on real-world asthma trials 27:40 How to lessen the disparities of asthma 31:14 Outro   For additional news and insights, visit us at HCPLive.com and Lung.org.

In recognition of May’s Asthma Awareness Month, this episode highlights our conversation with Dr. Juan Carlos Cardet at University of South Florida and Dr. Elliot Israel at Brigham and Women’s Hospital about the most common respiratory disease in the U.S. It provides a deep dive into the guideline-supported SMART strategy, role of COVID-19 in current asthma risks, and research into the medical and financial impacts of asthma on the U.S. patient population. Episode highlights 0:16 The Discovery of Asthma 2:12 Introducing Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH 3:20 Defining the SMART asthma strategy 5:46 The slow rollout of SMART 10:19 The strategy and findings of the PREPARE trial 21:41 How to initiate patient-activated reliever-triggered inhaled corticosteroid 25:15 The effect of COVID-19 on real-world asthma trials 27:40 How to lessen the disparities of asthma 31:14 Outro For additional news and insights, visit us at <a href="http://hcplive.com/" rel="nofollow" target="_blank">HCPLive.com</a> and <a href="http://lung.org/" rel="nofollow" target="_blank">Lung.org</a>.

Modern Asthma Care & SMART Strategy with Drs. Juan Carlos Cardet & Elliot Israel

Dr. Elliot Israel is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Chowdhury B et al. The Risks and Benefits of Indracaterol - The FDA's Review. N Engl J Med 2011;365:2247-9.

NEJM Interview: Dr. Elliot Israel on the risks and benefits of long-acting beta agonists in the treatment of asthma and COPD.